Observational studyCardiovascular diabetology2025

Erythrocytosis incidence and thromboembolic risk in heart failure with reduced ejection fraction treated with SGLT2 inhibitors: a nationwide register-based cohort study.

Abdullahi Ahmed Mohamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.